Southern Ohio Medical Center (or SOMC) is a 222-bed 501(C)(3) not-for-profit hospital in Portsmouth, Ohio, providing emergency and surgical care, as well as a wide range of other health care services. SOMC employs 2,600 full-time employees and part-time employees, has a medical staff of more than 140 physicians and specialists, and is supported by approximately 800 regular volunteers. In 2020, Fortune magazine ranked Southern Ohio Medical Center at number 22 on their Fortune List of the Top 100 Companies to Work For in 2020 based on an employee survey of satisfaction.
Coronary artery disease (CAD) places a disproportionate burden on rural Appalachian communities; Scioto County, Ohio has among the highest CAD-related hospitalization rates in the state. Single-photon emission computed tomography (SPECT) myocardial perfusion imaging is widely used, yet its performance in high-burden populations with substantial comorbidity is poorly characterized. We evaluated the sensitivity of SPECT for predicting subsequent revascularization and identified predictors of false-negative results. Retrospective analysis of prospectively collected American College of Cardiology CathPCI registry data at a single community hospital, including all cardiac catheterizations from Q3 2013 to Q1 2018. Sensitivity was calculated using subsequent revascularization (percutaneous coronary intervention or coronary artery bypass grafting) as the primary reference standard, with angiographic ≥ 70
Background Dysvascular amputation is a signifier of widespread disease, and one-year mortality estimates are around 44-48%, comparable to stage IV colon cancer (48%) and higher than stage IV CHF (30%) and COPD with exacerbation (23%) (1-4). Palliative care establishment demonstrates benefits in improving quality of life, reducing symptom burden, alleviating pain, and aligning treatments with patient goals (5). Palliative care consultation has been associated with lower in-hospital mortality for patients undergoing amputation (6). Despite this, palliative care consultation rates are much lower among patients undergoing dysvascular amputation as compared with colon cancer, CHF, and COPD (7). Objectives Identify patterns of palliative care consultation and associated mortality for patients hospitalized for initial major lower limb dysvascular amputation. Methods Retrospective chart review extracted data from a single center on adult patients (≥ 18 years old) with transmetatarsal, transtibial, knee disarticulation, or transfemoral amputation between June 1, 2018 and June 1, 2022. Chart review identified n=389 patients with first major lower limb amputation due to dysvascular etiology. Patients with prior major dysvascular amputation, or amputations due to trauma, malignancy, arteriovenous (AV) malformation, or failed joint replacement, were excluded. Results Of n=389 patients, 10 (2.6%) died during the index hospitalization; 30-day mortality was 3.8% (n=15) and one-year mortality was 21.9% (n=85). 25 patients (6.4%) received palliative care consultation during their index hospitalization; of those, 56% (14/25) died within one year. Overall, 16.5% (n=14/85) of the patients who died within one year had palliative care consultations during their index hospitalization. Outside of index hospitalization, 26.2% (n=102/389) were seen by palliative care. Conclusion Patients undergoing dysvascular major lower limb amputation may benefit from palliative care consultation at or near the time of their amputation surgery to improve quality of life, reduce symptom burden, and align care goals with treatment.
OBJECTIVES:To evaluate the efficacy and safety of conservative (oxygen saturation [Sp o2 ] 88-94% or Pa o2 < 80 mm Hg) vs. liberal oxygen targets (Sp o2 ≥ 94% or Pa o2 ≥ 90 mm Hg) in mechanically ventilated critically ill adults. DATA SOURCES:PubMed, Cochrane CENTRAL, Embase, and ClinicalTrials.gov . STUDY SELECTION:We conducted the OXY-BREATHES, a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing conservative vs. liberal oxygen targets in mechanically ventilated ICU patients. Primary outcomes were 90-day mortality and ICU length of stay. Secondary outcomes included ventilator- and vasopressor-free days, renal replacement therapy, nosocomial pneumonia, and cardiac or cerebral ischemic events. Subgroup analyses included patients with sepsis/septic shock and post-cardiac arrest. DATA EXTRACTION:Data were collected according to study selection criteria. Certainty of evidence was appraised with Grading of Recommendations, Assessment, Development, and Evaluation, and risk of bias with the Cochrane tool. Data were analyzed using a random-effects model. DATA SYNTHESIS:Nine RCTs enrolling 20,447 patients were included. Conservative and liberal targets showed no substantial differences in 90-day (risk ratio [RR], 1.01; 95% CI, 0.94-1.09) or ICU length of stay (mean difference [MD], -0.17; 95% CI, -0.41 to 0.06). Secondary outcomes, including organ support-free days and the incidence of adverse events, were comparable between groups. In subgroup analyses, conservative targets yielded more vasopressor-free days in septic patients (MD, 2.0; p = 0.008) and a potential survival benefit in post-cardiac arrest patients (RR, 0.89; p = 0.05). Certainty of evidence was rated moderate for 90-day mortality, ICU length of stay, vasopressor-free days, and ventilator-free days; low for renal replacement therapy and nosocomial pneumonia; and very low for cerebral and cardiac ischemia due to imprecision and open-label trial designs. CONCLUSIONS:Conservative oxygenation is comparable to liberal oxygen targets in mechanically ventilated critically ill patients, with possible advantages in sepsis and post-cardiac arrest. Future condition-specific RCTs are warranted to define optimal ICU oxygen strategies.
BACKGROUND:Systemic venous congestion is a key determinant of prognosis in acute heart failure (AHF). The Venous Excess Ultrasound (VExUS) score has emerged as a bedside tool to assess congestion, but its prognostic value in AHF remains uncertain. We aimed to evaluate the association between VExUS and in-hospital mortality in patients hospitalized with AHF. METHODS:PubMed, Embase, and the Cochrane Library were searched for studies assessing the prognostic value of VExUS in AHF. Patients with VExUS ≤1 were compared to those with VExUS ≥2 for the primary endpoint of in-hospital mortality. A Bayesian random-effects meta-analysis estimated marginal posterior distributions for overall effect and heterogeneity. RESULTS:Five studies including 565 patients were analyzed, most with VExUS grade 3 and reduced ejection fraction. In-hospital mortality occurred in 1.9% of patients with VExUS ≤1 (4/210) and in 14.1% with VExUS ≥2 (50/355), corresponding to a mean odds ratio of 0.175 (95% CrI: 0.061-0.497). The posterior probability of an association (OR<1) was 99.91%, and of a clinically relevant effect (OR<0.8) was 99.93%. The predictive distribution showed a 95% probability that the true odds ratio in a future study would range from 0.045 to 0.681. Sensitivity analyses using weakly informative and vague priors yielded consistent results. CONCLUSION:Lower VExUS grades were associated with reduced in-hospital mortality, supporting the role of VExUS as a bedside tool for prognostic risk stratification in acute heart failure.